1. Raman image-activated cell sorting Nitta, Nao, Iino, Takanori, Isozaki, Akihiro, Yamagishi, Mai, Kitahama, Yasutaka, Sakuma, Shinya, Suzuki, Yuta, Tezuka, Hiroshi, Oikawa, Minoru, Arai, Fumihito, Asai, Takuya, Deng, Dinghuan, Fukuzawa, Hideya, Hase, Misa, Hasunuma, Tomohisa, Hayakawa, Takeshi, Hiraki, Kei, Hiramatsu, Kotaro, Hoshino, Yu, Inaba, Mary, Inoue, Yuki, Ito, Takuro, Kajikawa, Masataka, Karakawa, Hiroshi, Kasai, Yusuke, Kato, Yuichi, Kobayashi, Hirofumi, Lei, Cheng, Matsusaka, Satoshi, Mikami, Hideharu, Nakagawa, Atsuhiro, Numata, Keiji, Ota, Tadataka Nature communications (2020)
2. Intelligent Image-Activated Cell Sorting. Nao Nitta, Takeaki Sugimura, Akihiro Isozaki, Hideharu Mikami, Kei Hiraki, Shinya Sakuma, Takanori Iino, Fumihito Arai, Taichiro Endo, Yasuhiro Fujiwaki, Hideya Fukuzawa, Misa Hase, Takeshi Hayakawa, Kotaro Hiramatsu, Yu Hoshino, Mary Inaba, Takuro Ito, Hiroshi Karakawa, Yusuke Kasai, Kenichi Koizumi, SangWook Lee, Cheng Lei, Ming Li, Takanori Maeno, Satoshi Matsusaka, Daichi Murakami, Atsuhiro Nakagawa, Yusuke Oguchi, Minoru Oikawa, Tadataka Ota, Kiyotaka Shiba, Hirofumi Shintaku, Yoshitaka Shirasaki, Kanako Suga, Yuta Suzuki, Nobutake Suzuki, Yo Tanaka, Hiroshi Tezuka, Chihana Toyokawa, Yaxiaer Yalikun, Makoto Yamada, Mai Yamagishi, Takashi Yamano, Atsushi Yasumoto, Yutaka Yatomi, Masayuki Yazawa, Dino Di Carlo, Yoichiroh Hosokawa, Sotaro Uemura, Yasuyuki Ozeki, Keisuke Goda 175 (1) 266 - 276 (2018)
3. Prognostic Value of ACVRL1 Expression in Metastatic Colorectal Cancer Patients Receiving First-line Chemotherapy With Bevacizumab: Results From the Triplet Plus Bevacizumab (TRIBE) Study. Hanna DL, F, Loupakis, D, Yang, C, Cremolini, M, Schirripa, M, Li, S, Matsusaka, MD, Berger, Y, Miyamoto, W, Zhang, Y, Ning, C, Antoniotti, L, Salvatore, M, Moran, G, Zeger, SH, Astrow, A, Falcone, HJ, Lenz Clin Colorectal Cancer. 17 (3) e471 - e488 (2018)
4. A Feasibility Study of Capecitabine and Oxaliplatin for Patients with Stage II/III Colon Cancer -ACTOR Study. M, Suenaga, T, Akiyoshi, E, Shinozaki, Y, Fujimoto, S, Matsusaka, T, Konishi, S, Nagayama, Y, Fukunaga, K, Kawakami, T, Yokokawa, T, Sugisaki, M, Ueno, T, Yamaguchi Anticancer Res 17 (3) e471 - e488 (2018)
5. Multicenter phase II study of trastuzumab plus S-1 alone in elderly patients with HER2-positive advanced gastric cancer (JACCRO GC-06) Yutaka Kimura, Masashi Fujii, Toshiki Masuishi, Kazuhiro Nishikawa, Chikara Kunisaki, Satoshi Matsusaka, Yoshihiko Segawa, Masato Nakamura, Kinro Sasaki, Narutoshi Nagao, Yukimasa Hatachi, Yasuhiro Yuasa, Shinya Asami, Masahiro Takeuchi, Hiroshi Furukawa, Toshifusa Nakajima, Tomono Kawase, Ryohei Kawabata, Tetsuya Etou, Hirochika Makino, Hidetaka Ono, Yusuke Izumisawa, Junji Kawada, Ken Shimada, Yu Sunakawa, Hitoshi Satomura, Katsuyuki Kunieda, Akihito Tsuji, Hironaga Satake, Hisashi Ishikura, Hiroshi Okitsu, Takahiro Ito, Kentaro Moriichi, Masazumi Takahashi, Yasutaka Takinishi, Takashi Sekikawa, Naoki Okumura, Shigemitsu Ueyama, Noriyuki Yamamura, Dai Manaka, Sachiko Oouchi, Ryuichiro Ohashi, Tomohiko Mannami, Kazuaki Tanabe, Takeshi Shiraishi, on behalf of the JACCRO GC-06 Study Group 21 (3) 421 - 427 (2018)
6. Prognostic impact of FOXF1 polymorphisms in gastric cancer patients. Matsusaka, S, Wu, AH, Cao, S, Hanna, DL, Chin, K, Yang, D, Zhang, W, Ning, Y, Stintzing, S, Sebio, A, Sunakawa, Y, Stremitzer, S, Yamauchi, S, Okazaki, S, Berger, MD, Parekh, A, Miyamoto, Y, Mizunuma, N, Lenz, HJ Pharmacogenomics J. 18 (2) 262 - 269 (2018)
7. A Polymorphism within the Vitamin D Transporter Gene Predicts Outcome in Metastatic Colorectal Cancer Patients Treated with FOLFIRI/Bevacizumab or FOLFIRI/Cetuximab. Martin D Berger, Sebastian Stintzing, Volker Heinemann, Shu Cao, Dongyun Yang, Yu Sunakawa, Satoshi Matsusaka, Yan Ning, Satoshi Okazaki, Yuji Miyamoto, Mitsukuni Suenaga, Marta Schirripa, Diana L Hanna, Shivani Soni, Alberto Puccini, Wu Zhang, Chiara Cremolini, Alfredo Falcone, Fotios Loupakis, Heinz-Josef Lenz 24 (4) 784 - 793 (2018)
8. A genetic variant in Rassf1a predicts outcome in mCRC patients treated with cetuximab plus chemotherapy: Results from FIRE-3 and JACCRO 05 and 06 trials A. Sebio, S. Stintzing, V. Heinemann, Y. Sunakawa, W. Zhang, W. Ichikawa, A. Tsuji, T. Takahashi, A. Parek, D. Yang, S. Cao, Y. Ning, S. Stremitzer, S. Matsusaka, S. Okazaki, A. Barzi, M. D. Berger, H. J. Lenz 18 (1) 43 - 48 (2018)
9. CXCR4 polymorphism predicts progression-free survival in metastatic colorectal cancer patients treated with first-line bevacizumab-based chemotherapy S. Matsusaka, S. Cao, D. L. Hanna, Y. Sunakawa, M. Ueno, N. Mizunuma, W. Zhang, D. Yang, Y. Ning, S. Stintzing, A. Sebio, S. Stremitzer, S. Yamauchi, A. Parekh, S. Okazaki, M. D. Berger, R. El-Khoueiry, A. Mendez, W. Ichikawa, F. Loupakis, H-J Lenz 17 (6) 543 - 550 (2017)
10. Genetic variations in immunomodulatory pathways to predict survival in patients with locoregional gastric cancer Y. Sunakawa, S. Cao, N. B. Volz, M. D. Berger, D. Yang, A. Parekh, W. Zhang, S. Matsusaka, Y. Ning, S. Stremitzer, S. Stintzing, A. Sebio, S. Okazaki, T. Wakatsuki, M. Azuma, M. Watanabe, W. Koizumi, A. H. Wu, H-J Lenz 17 (6) 528 - 534 (2017)

researchmap の論文リストを表示する Show the publication list on researchmap